Nervous Disorder TRIZ Cases

Synthetic promoters enable targeted gene expression in specific central nervous system regions.

Sulfocalixarene derivatives release alpha-synuclein from membranes and bind monomers to block toxic oligomer formation.

Segmented dipeptide mimetics cross biological barriers to provide neuroprotection without full protein degradation or adverse pain syndromes.

Genome-wide association study detects copy number variations and single nucleotide polymorphisms to overcome linkage analysis limitations.

Viral vectors deliver neuropeptide combinations to target brain regions, preventing receptor downregulation and sustaining therapeutic efficacy.

Direct MHC binding by PLP peptides induces tolerance, reducing adverse effects in multiple sclerosis treatment.

Freeze-dried fertilized egg isolates antagonize glutamate and neurokinin receptors, reducing side effects of traditional antidepressants.

Peptidomimetic calpain inhibitors cross the blood-brain barrier to reduce infarct volume while avoiding side effects from non-selective protease inhibition.

An integrated patch tag tracks application events to prevent rivastigmine overdose in elderly patients.

N-heteroarylalkyl acetamide derivatives modulate somatostatin receptor 4 to regulate biological activity.

NCAM peptide mimetics target neural adhesion mechanisms to reduce depression symptoms while avoiding adverse events from traditional medications.

Combining ketorolac salts with B-complex vitamins reduces opioid side effects while maintaining formulation stability through specific buffer solutions.

Differentiating stem cells into microglia using Wnt pathway modulation to generate authentic cell models.

Full-length amelogenin accelerates nerve regeneration by aligning free nerve endings parallel to collagen fibers, resolving slow spontaneous recovery.

Domain V protein fragment extends the therapeutic window for stroke treatment by stimulating endogenous neuronal proliferation and synaptic restoration.

Cold water agitation isolates trichomes from cannabis trimmings, raising active compound concentration while removing unwanted toxins.

Humanized antibodies bind the CSF1R extracellular domain to block ligand interaction.

Fully human monoclonal antibodies bind IL-33 to block ST2 receptor interaction, reducing inflammatory cytokine production and side effects.

Novel glucagon analogue peptides act as dual agonists on glucagon and GLP-1 receptors to promote weight loss.

Mutated Fc variants improve brain exposure by utilizing FcRn-mediated transport, bypassing safety liabilities associated with transferrin receptor targeting.

A p75NTR fusion protein binds excess NGF to relieve pain while preserving bone and cartilage repair mechanisms.

Fixed dosing of anti-C1s antibody inhibits complement component C4 activation, resolving dosage control complexity in treating complement-mediated diseases.

Cinnamate compounds inhibit proteasome activity, offering effective treatment for skin disorders with reduced side effects compared to existing therapies.

Pharmaceutical composition of cannabidivarin and cannabidiol reduces seizure severity and mortality while avoiding THC side effects.

GM-CSF treatment reduces amyloid plaque burden and reverses cognitive decline in Alzheimer's disease pathology.

Administering selective serotonin 5-HT1A receptor agonists counteracts VMAT inhibitor-induced depression and Parkinsonism, improving therapeutic tolerability.

Co-administering xanomeline with atypical antipsychotics enhances therapeutic efficacy through muscarinic receptor activation.

Direct intralymphatic injection of mesenchymal stem cells modulates autoreactive T cells to treat autoimmune diseases while preserving protective immunity.

Effervescent oral opiate dosage forms utilize pH adjustment and effervescence to enhance buccal absorption of active ingredients.

Small molecule splicing modulators based on 5-pyrimidinecarboxamide derivatives target RNA cis-elements to alter transcript sequences.

Segmented variable regions optimize binding affinity, lowering myeloperoxidase levels and improving locomotor recovery after spinal cord injury.

Segmented intra-pore films in a porous substrate preserve handling characteristics by avoiding continuous surface coatings that stiffen implants.

Anti-IL-1α antibodies target specific molecular mechanisms to suppress tumor growth while avoiding the severe side effects of conventional chemotherapy.

HLA-derived peptide epitopes bind MHC molecules to activate T cells, reducing tumor growth without severe side effects.

Dual-action compounds inhibit acetylcholinesterase and stimulate 5-HT4 receptors to restore cholinergic transmission.

High boundary layer perimeter flow chamber applies controlled shear stress to stem cells, resolving mechanical control precision limits in bioreactors.

Target Abductor Hallucis and Quadratus Plantae muscles with botulinum toxin injections to resolve ineffective plantar fascia treatments.

A bispecific antibody links alpha-synuclein targeting to IGF1R receptors for brain delivery.

T1h humanized antibody targets SRCR domain 1 of CD6 to inhibit T cell proliferation while preserving natural ligand interactions and avoiding cytotoxicity.

Administering ICAM-1 boosts neprilysin levels in neurons, degrading amyloid-beta plaques that cause Alzheimer's disease progression.

Ligand-selective ActRIIB variants minimize off-target effects while Fc fusion extends protein half-life for treating muscle wasting disorders.

Assesses neutrophil phagocytosis via plasma contact to predict infection risk and mortality in alcoholic liver cirrhosis.

Human monoclonal antibodies target alpha-synuclein aggregates, eliminating cross-reactivity and the human anti-mouse antibody response.

Engineered anti-C6 antibodies bind human complement component C6 with high affinity to block membrane attack complex formation.

Novel TRPV1 modulator compounds utilize metabolically labile ester bonds to achieve antinociceptive effects without toxicity.

Monoclonal antibodies target conformational epitopes on alpha-synuclein fibrils to differentiate them from monomers for precise neuropathology detection.